Characterization of the molecular mechanisms underlying increased ischemic damage in the aldehyde dehydrogenase 2 genetic polymorphism using a human induced pluripotent stem cell model system.
about
Reprogramming and transdifferentiation for cardiovascular development and regenerative medicine: where do we stand?Mitoconfusion: noncanonical functioning of dynamism factors in static mitochondria of the heartTranslation of Human-Induced Pluripotent Stem Cells: From Clinical Trial in a Dish to Precision MedicineInherited heart disease - what can we expect from the second decade of human iPS cell research?Effects of the common polymorphism in the human aldehyde dehydrogenase 2 (ALDH2) gene on the lungInduced pluripotent stem cell: A headway in reprogramming with promising approach in regenerative biologyMitochondrial reactive oxygen species at the heart of the matter: new therapeutic approaches for cardiovascular diseases.Engineered heart tissues and induced pluripotent stem cells: Macro- and microstructures for disease modeling, drug screening, and translational studies.Human-induced pluripotent stem cell approaches to model inborn and acquired metabolic heart diseases.Mitochondrial aldehyde dehydrogenase obliterates insulin resistance-induced cardiac dysfunction through deacetylation of PGC-1α.Patient-Specific and Genome-Edited Induced Pluripotent Stem Cell-Derived Cardiomyocytes Elucidate Single-Cell Phenotype of Brugada Syndrome.Current status of pluripotent stem cells: moving the first therapies to the clinic.Human AML-iPSCs Reacquire Leukemic Properties after Differentiation and Model Clonal Variation of Disease.Danshen-Enhanced Cardioprotective Effect of Cardioplegia on Ischemia Reperfusion Injury in a Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes Model.Induced pluripotent stem cells: at the heart of cardiovascular precision medicine.Human Induced Pluripotent Stem Cells as a Platform for Personalized and Precision Cardiovascular Medicine.Evidence that Environmental Heterogeneity Maintains a Detoxifying Enzyme Polymorphism in Drosophila melanogaster.Alcohol Dehydrogenase 5 Is a Source of Formate for De Novo Purine Biosynthesis in HepG2 Cells.Recreating the Cardiac Microenvironment in Pluripotent Stem Cell Models of Human Physiology and Disease.Molecular Approaches in HFpEF: MicroRNAs and iPSC-Derived Cardiomyocytes.Concise Review: Induced Pluripotent Stem Cell Research in the Era of Precision Medicine.Human heart disease: lessons from human pluripotent stem cell-derived cardiomyocytes.Disruption of the Aldehyde Dehydrogenase 2 Gene Results in No Increase in Trabecular Bone Mass Due to Skeletal Loading in Association with Impaired Cell Cycle Regulation Through p21 Expression in the Bone Marrow Cells of Mice.Aldehyde dehydrogenase 2 overexpression inhibits neuronal apoptosis after spinal cord ischemia/reperfusion injury.Fast two-photon imaging of subcellular voltage dynamics in neuronal tissue with genetically encoded indicators.Human pluripotent stem cell models of cardiac disease: from mechanisms to therapies.Induced Pluripotent Stem Cell Model of Pulmonary Arterial Hypertension Reveals Novel Gene Expression and Patient Specificity.Activation of aldehyde dehydrogenase 2 slows down the progression of atherosclerosis via attenuation of ER stress and apoptosis in smooth muscle cells.Comparison of Non-human Primate versus Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes for Treatment of Myocardial Infarction.Alkynol natural products target ALDH2 in cancer cells by irreversible binding to the active site.SETD7 Drives Cardiac Lineage Commitment through Stage-Specific Transcriptional Activation.Pluripotent Stem Cell-Derived Cardiomyocytes as a Platform for Cell Therapy Applications: Progress and Hurdles for Clinical Translation.
P2860
Q26800082-84ACAD60-D1DD-4D1A-A3BC-101B868D1922Q27001001-457C568F-28B7-45A3-A543-4FB693EF2D78Q28076397-5D87A779-41F8-4E53-B73C-786FEB7967C6Q28079217-3D8678AD-335D-4680-B0FF-C2CB03EAAA7BQ33588858-A8465E9C-8412-48E0-A11E-4A3B9E094764Q33877155-9E3EB6BA-176D-4B46-84BB-E7F0F19522E4Q35645530-16865CB6-9F11-4C24-A663-E8FA66ED7E08Q36421944-92EC9023-A1F0-430C-B4EA-BEBC35634701Q37153107-C0B55099-71B3-4C9E-ACB7-C8E851C45181Q37718230-1947CEC3-E5EE-47E6-B30E-4055F4F615FEQ37730325-6F8BA266-BCF5-4BF0-BF08-AA660BDFF9B7Q38590664-6058B17E-2F97-4E58-92EB-6A563FDD448DQ38721210-966EF720-1345-4B61-89DE-BF52D857056AQ38786228-3984904D-2DAB-4C15-80BB-F10924E8E48CQ38786687-870FC95B-415C-492B-A953-4B46B74C3852Q38874111-A38E0398-2024-4CDA-8DD8-4A916A0F9525Q38937213-9AFB49C2-C859-4222-AE7C-9981E1C1832BQ38947506-4C2166DC-AE50-4DB4-ADDE-44A16C49845FQ39050847-0866877B-7E64-4861-B256-D88B24360943Q39061922-967CB624-55D7-4148-83EE-EBD28301ECF6Q39093960-EBE72CD7-8B71-47D7-946F-E9A2A00C7351Q39345477-BE9AE784-E4B0-4340-8CA7-C068610E9B19Q41261349-2D7BE6DA-77EE-4C70-927C-9917A96745C6Q41429918-124A6313-68CE-40F7-A988-8690F050F4DAQ41618403-1E444575-5ACD-4D43-A7B6-7D2C6A7323E7Q41664792-141CBDD8-BF34-4F97-9485-835951E6D63DQ46516719-CE8FF2D7-6FE0-4D54-BCEA-D6B7EFF26EBEQ47877255-F0411841-E7C9-4B86-B424-E458650D57B9Q49341169-AC4A77B8-D43B-49F9-AF27-A95F7ED1FA2FQ50936073-9002EF1C-4BB4-4346-AB92-E61A89705C6AQ51418450-D93A50F6-8058-479A-A011-4AA4B6544943Q52560413-1AB0215E-A3A4-4E18-8D17-A7B18EF0F1BE
P2860
Characterization of the molecular mechanisms underlying increased ischemic damage in the aldehyde dehydrogenase 2 genetic polymorphism using a human induced pluripotent stem cell model system.
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Characterization of the molecu ...... potent stem cell model system.
@ast
Characterization of the molecu ...... potent stem cell model system.
@en
type
label
Characterization of the molecu ...... potent stem cell model system.
@ast
Characterization of the molecu ...... potent stem cell model system.
@en
prefLabel
Characterization of the molecu ...... potent stem cell model system.
@ast
Characterization of the molecu ...... potent stem cell model system.
@en
P2093
P2860
P1476
Characterization of the molecu ...... potent stem cell model system.
@en
P2093
Antje D Ebert
Bruno C Huber
Jaecheol Lee
Jared Churko
Johannes Riegler
Joseph D Gold
Kazuki Kodo
Patricia de Almeida
P2860
P304
P356
10.1126/SCITRANSLMED.3009027
P407
P577
2014-09-01T00:00:00Z